Drug_ID,Drug,Y,Permeability,Binary
D,CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21,-5.489058,3.242963047066713e-06,0
Angelol-B,C/C=C(/C)C(=O)O[C@@H]([C@@H](O)c1cc2ccc(=O)oc2cc1OC)C(C)(C)O,-4.8499289,1.4127688154425806e-05,1
Flavone,O=c1cc(-c2ccccc2)oc2ccccc12,-3.9201083,0.00012019646633552732,1
enalapril,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O,-5.6719999,2.128139536004891e-06,0
Furazolidone,O=C1OCCN1/N=C/c1ccc(N(O)O)o1,-4.9899998,1.0232934635247014e-05,1
Val-ACV,CC(C)C(N)C(=O)OCCOCn1cnc2c(=O)[nH]c(N)nc21,-5.6697760000000015,2.13906509000867e-06,0
Neostenine,CC[C@@H]1C2CCCCN3CCC(C23)[C@@H]2[C@H](C)C(=O)O[C@H]12,-4.9198675000000005,1.2026312924692207e-05,1
Efavirenz,O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1,-4.0500002,8.912505276976145e-05,1
Capric acid (decanoic acid),CCCCCCCCCC(=O)O,-4.6799998,2.0892970930106858e-05,1
EF5289,CCOC(=O)COc1ccc(C(=O)CN2CCN(C3CCN(C(=O)OCOC(=O)C(C)(C)C)CC3)CC2=O)cc1,-4.2600002,5.495406207847576e-05,1
Bilirubin,C=CC1=C(C)/C(=C\c2[nH]c(Cc3[nH]c(/C=C4/NC(=O)C(C)=C4C=C)c(C)c3CCC(=O)O)c(CCC(=O)O)c2C)NC1=O,-6.1314831,7.387830112059346e-07,0
51d,COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)NS(=O)(=O)C6CC6)C[C@H]5/C=C\CCCCN(C)C(=O)[C@@H]4C3)nc(-c3cccc(F)c3)nc2c1C,-5.3000002,5.011870028220744e-06,0
hexapeptide 47,C[C@@H]1NC(=O)[C@@H](C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@@H](C)N(C)C1=O,-5.3000002,5.011870028220744e-06,0
VACV,C=C1NC(N)=Nc2c1ncn2COCCOC(=O)[C@H](N)C(C)C,-5.3499999,4.466836950036728e-06,0
Oxaprozin,O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1,-4.48,3.3113112148259076e-05,1
Setrobuvir (ANA598),CS(=O)(=O)Nc1ccc2c(c1)S(=O)(=O)N/C(=C1\C(=O)[C@@H]3[C@H]4CC[C@H](C4)[C@@H]3N(Cc3ccc(F)cc3)C1=O)N2,-5.8899999,1.2882498483235886e-06,0
fexofenadine,CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,-6.5100002,3.0902940093802763e-07,0
Salvianolic acid A (SAA),O=C(/C=C/c1ccc(O)c(O)c1/C=C/c1ccc(O)c(O)c1)OC(Cc1ccc(O)c(O)c1)C(=O)O,-7.2277412,5.9191425614525993e-08,0
E25,NC(=O)/C=C(\c1cccc(F)c1)c1ccc2nc(N)n(S(=O)(=O)NC(=O)N3CCOCC3)c2c1,-4.7399998,1.819701696613392e-05,1
8,COc1cc(C)ccc1S(=O)(=O)NC(=O)C(c1ccc2c(c1)OCO2)c1cn(C)c2cc(C#N)ccc12,-5.1011863,7.921614428207836e-06,0
Netivudine (882C87),CC#Cc1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)[nH]c1=O,-5.1687455,6.7803872726724416e-06,0
679-Captopril (Cap),C[C@H](CS)C(=O)N1CCC[C@@H]1C(=O)O,-4.8153086,1.5299998914309847e-05,1
Bromazepam,O=C1CN=C(c2ccccn2)c2cc(Br)ccc2N1,-4.4000001,3.981070788859444e-05,1
-,OCc1ccncc1,-4.0902224,8.124143763427843e-05,1
CPU-86017,COc1ccc2c(c1OC)C[N+]1(Cc3ccc(Cl)cc3)CCc3cc4c(cc3C1C2)OCO4.[Cl-],-6.2314224000000005,5.869182311537132e-07,0
PNU200681,Cc1ccnc2[nH]c(Cc3nc4ccc(/C(N)=N\O)cc4[nH]3)nc12,-6.6994848,1.9976306828816264e-07,0
N-Acetyl-D-alanine Phenethylamide (8),CC(=O)N[C@H](C)C(=O)NCCc1ccccc1,-4.6095328,2.457351033283185e-05,1
Org 13011,O=C1CCCN1CCCCN1CCN(c2cc(C(F)(F)F)ccn2)CC1,-4.7399998,1.819701696613392e-05,1
CD1,CCCCCCCCCC(=O)OC,-3.51,0.0003090295432513592,1
Nitrendipine,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(N(O)O)c1,-4.6200309,2.398662248418335e-05,1
hexapeptide 03,C[C@@H]1NC(=O)[C@H](C)NC(=O)[C@@H](C)N(C)C(=O)[C@H](C)NC(=O)[C@@H](C)NC(=O)[C@@H](C)NC1=O,-5.8200002,1.5135605514156553e-06,0
366853,CC(C)n1c(N)nc2ccc(C(C(N)=O)c3cccc(F)c3F)cc21,-5.187450900000001,6.494550528189304e-06,0
014-Ampicillin,CC1(C)S[C@]2(C)[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)O,-6.1023731,7.899996520346862e-07,0
11,CNC(=O)[C@H](NC(=O)[C@](O)(Cc1ccccc1)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@H](CC(=O)OC)C(C)(C)C)C(C)(C)C,-5.4699998,3.38844312182739e-06,0
N-Acetyl-D-alanyl-D-phenylalanine N-Methylamide (2),CNC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](C)NC(C)=O,-5.7484403,1.7846773011486722e-06,0
a,O=C(O)CC(CC1CCN(C(=O)CCc2ccc3c(n2)NCCC3)CC1)c1cnc2ccccc2c1,-5.8899999,1.2882498483235886e-06,0
XM970,CCCCC(=O)NS(=O)(=O)c1ccccc1-c1ccc(Cn2c(CCC)nc(CC)c2C(=O)O)c(F)c1,-5.1999998,6.309576350468559e-06,0
EF5292,CC(C)(C)C(=O)OCOC(=O)N1CCC(N2CCN(CC(=O)c3ccc(OCC(=O)OC4CCCCC4)cc3)C(=O)C2)CC1,-4.4400001,3.630779711682995e-05,1
Valsartan,CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)[C@H](C(=O)O)C(C)C,-6.2600002,5.495406207847576e-07,0
"Dimethyl-4',4'-dimethoxy-5,6,5',6'-dimethylene dioxybiphenyl-2,2'-dicarboxylate (DDB)",COC(=O)c1cc(OC)c2c(c1-c1c(C(=O)OC)cc(OC)c3c1OCO3)OCO2,-4.1687455,6.780387272672443e-05,1
801-Yohimbine (YOH),COC(=O)[C@@H]1[C@H](O)CC[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@H]3C[C@H]21,-4.8124795,1.5399992169182864e-05,1
XI,CCCCOc1cccc(NC(=O)OCCN2CCCC2)c1,-4.5900002,2.5703945990581314e-05,1
hexapeptide 37,C[C@@H]1NC(=O)[C@@H](C)NC(=O)[C@@H](C)NC(=O)[C@H](C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@@H](C)N(C)C1=O,-5.8200002,1.5135605514156553e-06,0
lamotrigine,Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1,-4.3899999,4.073803716068987e-05,1
methanol,CO,-4.4899998,3.235938059500489e-05,1
Amitriptyline,CN(C)CCC=C1c2ccccc2CCc2ccccc21,-4.2600002,5.495406207847576e-05,1
Prednisolone,C[C@]12CC(O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO,-5.369999900000002,4.265796170251665e-06,0
hexapeptide 53,C[C@@H]1NC(=O)[C@@H](C)NC(=O)[C@@H](C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@@H](C)N(C)C1=O,-5.3000002,5.011870028220744e-06,0
7,COC(=O)C1CCN(C(=O)CC(Cc2cccc(C(=N)N)c2)NS(=O)(=O)c2ccc3ccccc3c2)CC1,-7.0912943,8.104116956089034e-08,0
Ac-D-phe-NH2,CC(=O)N[C@@H](Cc1ccccc1)C(N)=O,-5.10009,7.941636410277657e-06,0
LY366092,CNC(=O)/C=C(/c1ccc2nc(N)n(S(=O)(=O)C(C)C)c2c1)c1ccccc1-c1cccc2ccccc12,-4.0300002,9.33253871017602e-05,1
V,CC(C)C[C@H](O)[C@H](O)[C@H](CC1CCCCC1)NC(=O)CCCCCc1ccccc1,-5.1500001,7.0794562137361614e-06,0
CF 1572 (p-I),COC(=O)C(C)NP(=O)(OC[C@@H]1C=C[C@H](n2cc(C)c(=O)[nH]c2=O)O1)Oc1ccc(I)cc1,-5.130000099999998,7.413100706079488e-06,0
3,Cc1c(O)c2c(c(C)c1CCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C(=O)C(C)(C)C2,-6.0107207,9.756168669370452e-07,0
Emetine,CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21,-5.6900001,2.041737474542049e-06,0
hexapeptide 55,C[C@@H]1NC(=O)[C@@H](C)N(C)C(=O)[C@H](C)NC(=O)[C@@H](C)N(C)C(=O)[C@@H](C)N(C)C(=O)[C@H](C)N(C)C1=O,-5.3000002,5.011870028220744e-06,0
tiotidine,C/N=C(\NC#N)NCCSCc1csc(N=C(N)N)n1,-5.880000099999998,1.3182564350166154e-06,0
tryptophanamide,NC(=O)C(N)Cc1c[nH]c2ccccc12,-4.920000099999998,1.2022641577858326e-05,1
Scopolamine,CN1C2CC(OC(=O)C(CO)c3ccccc3)CC1C1OC12,-4.724059099999999,1.8877344434674052e-05,1
(-)-Epicatechin (36),Oc1cc(O)c2c(c1)O[C@H](c1ccc(O)c(O)c1)[C@H](O)C2,-6.4311924000000005,3.705165401537425e-07,0
Liquiritigenin (LG),O=C1CC(c2ccc(O)cc2)Oc2cc(O)ccc21,-4.8000002,1.5848924625909923e-05,1
hexapeptide 09,C[C@@H]1NC(=O)[C@H](C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](C)N(C)C(=O)[C@@H](C)NC1=O,-5.3000002,5.011870028220744e-06,0
67c,COc1ccc2c(O[C@H]3C[C@H]4C(=O)NCCCCC/C=C\[C@@H]5C[C@@]5(C(=O)NS(=O)(=O)C5CC5)NC(=O)[C@@H]4C3)nc(-c3ccc(F)cc3)nc2c1C,-4.4899998,3.235938059500489e-05,1
Brucine (Bru),COc1cc2c(cc1OC)[C@]13CCN4CC5=CCO[C@@H]6CC(=O)N2[C@@H]1[C@@H]6[C@@H]5C[C@@H]43,-4.7786422,1.664783642422596e-05,1
Captopril (Cap),C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O,-4.8200002,1.5135605514156553e-05,1
31,NC(=O)c1cccc(Cc2ncccn2)c1,-4.4609237,3.460001603007134e-05,1
Ketamine,CNC1(c2ccccc2Cl)CCCCC1=O,-4.2600002,5.495406207847576e-05,1
14c,Cn1c(C(=O)NC2(C(=O)N[C@H](Cc3ccccc3)C(=O)NCCCN3CCOCC3)CCCC2)cc2ccccc21,-4.9723473,1.0657435182751282e-05,1
4d,Cc1cc(C(=O)Nc2ccc(-c3ccccc3S(C)(=O)=O)cc2F)n(-c2cccc(CN)c2)n1,-5.5,3.162277660168379e-06,0
Thalidomide,O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1,-4.6999998,1.9952632338213456e-05,1
Salvianolic acid D (SAD),O=C(O)Cc1c(/C=C/C(=O)OC(Cc2ccc(O)c(O)c2)C(=O)O)ccc(O)c1O,-7.179570699999998,6.61346866234561e-08,0
Rhodamine 123 (Rho 123),COC(=O)c1ccccc1-c1c2ccc(=N)cc-2oc2cc(N)ccc12,-5.9411516,1.1451131448494157e-06,0
26,Cn1c(N2CCN(CCCCN3c4ccccc4Sc4ccc(C(=O)O)cc43)CC2)cc(=O)n(C)c1=O,-4.6900001,2.041737474542049e-05,1
45b,COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)NS(=O)(=O)C6CC6)C[C@H]5/C=C\CCCCN(C)C(=O)[C@@H]4C3)nc(-c3nc(C(C)C)cs3)nc2c1,-5.2199998,6.025598635633657e-06,0
Reserpine,COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC,-5.369999900000002,4.265796170251665e-06,0
MEN14732,O=C(NC1(C(=O)N[C@H](Cc2ccccc2)C(=O)NCCCN2CCOCC2)CCCC1)c1ccc(-c2ccccc2)cc1,-4.7399998,1.819701696613392e-05,1
Ergonovine,CC(CO)NC(=O)C1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,-5.1684265,6.7853694637716675e-06,0
Indinavir,CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O,-5.6900001,2.041737474542049e-06,0
60a,COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)NS(=O)(=O)C6CC6)C[C@H]5/C=C\CCCCCN(C)C(=O)[C@@H]4C3)nc(-c3ccccc3)nc2c1C,-4.5900002,2.5703945990581314e-05,1
hexapeptide 32,C[C@@H]1NC(=O)[C@@H](C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@@H](C)NC(=O)[C@@H](C)NC(=O)[C@H](C)N(C)C1=O,-5.8200002,1.5135605514156553e-06,0
368177,CNC(=O)C(c1ccc2nc(N)n(C3CCCC3)c2c1)c1ccccc1F,-4.907450700000001,1.237511661124267e-05,1
23,N#Cc1ccc(NCC(F)(F)c2ccc(F)c(F)c2)c(F)c1CC(=O)NCCONC(=N)N,-5.9430285000000005,1.1401749626346885e-06,0
Losartan,CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,-6.0727587,8.457486242328674e-07,0
theophylline,Cn1c(=O)c2[nH]cnc2n(C)c1=O,-4.3499999,4.4668369500367274e-05,1
hexapeptide 42,C[C@@H]1NC(=O)[C@@H](C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@@H](C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)N(C)C1=O,-5.8200002,1.5135605514156553e-06,0
Stavudine (d4T),Cc1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O,-5.3483939000000005,4.48338567648493e-06,0
Cycloserine,NC1CONC1=O,-5.4400001,3.630779711682995e-06,0
-,Cc1ccncc1,-3.9612868,0.00010932341763169412,1
neolignan smi09,C=CCc1cc(OC)c(OC(C)C(O)c2ccc(O)c(OC)c2)c(OC)c1,-4.5100002,3.090294009380277e-05,1
21d,CC(C)[C@H](NC(=O)[C@H](OCc1ccccc1)[C@H](O)[C@@H](O)[C@@H](OCc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O)C(=O)NCCF,-5.8000002,1.5848924625909923e-06,0
"453-(2E,4E,8Z,10Z)-N-Isobutyldodeca-2,4,8,10-tetraenamide (5) mw=247",C/C=C\C=C/CC/C=C/C=C/C(=O)NCC(C)C,-4.2441254,5.699996644367287e-05,1
8,COCCNC(=O)[C@H](NC(=O)[C@](O)(Cc1ccccc1)CN(Cc1ccc(Br)cc1)NC(=O)[C@H](CC(=O)OC)C(C)(C)C)C(C)C,-5.3200002,4.78629871905386e-06,0
Danazol,C#C[C@@]1(O)CC[C@@H]2[C@H]3CCC4=Cc5oncc5C[C@@]4(C)[C@@H]3CC[C@]21C,-4.561461,2.7449788337572374e-05,1
Nicardipine,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)Cc2ccccc2)C1c1cccc(N(O)O)c1,-4.9305754,1.1733419551417519e-05,1
Tanshinol (TSL),O=C(O)C(O)Cc1ccc(O)c(O)c1,-5.9118199,1.2251241474989238e-06,0
17d,CC(C)[C@@H](C(=O)N[C@H](C)Cc1ccc(O)c(C(C)(C)C)c1)N(C)C(=O)[C@@H](N)Cc1ccccc1,-4.9186072,1.2061263346970162e-05,1
PB-102,CC(C)COC(=O)N1CCC(CN(C2Cc3cc(C#N)ccc3N(Cc3cncn3C)C2)S(=O)(=O)c2ccccn2)CC1,-5.1224694,7.542765396243511e-06,0
hexapeptide 59,C[C@@H]1NC(=O)[C@@H](C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@@H](C)N(C)C(=O)[C@@H](C)N(C)C(=O)[C@H](C)N(C)C1=O,-5.3000002,5.011870028220744e-06,0
Glipizide,Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1,-4.7199998,1.905461595460538e-05,1
Promethazine,CC(CN1c2ccccc2Sc2ccccc21)N(C)C,-3.7777722,0.000166812196126655,1
6,NS(=O)(=O)c1ccc(Cl)cc1,-4.2620125,5.47000218735527e-05,1
247-Lobucavir,Nc1nc(=O)c2ncn([C@@H]3C[C@H](CO)[C@H]3CO)c2[nH]1,-6.0555172,8.800002590589407e-07,0
H 244/45,CCC(=O)Nc1ccc(OCC(O)CNC(C)C)cc1,-5.2198415,6.0277953619659036e-06,0
PNU-179397,CCC(=O)NC[C@H]1CN(c2ccc(-n3cc(C#N)cn3)c(F)c2)C(=O)O1,-4.3099999,4.897789321441998e-05,1
Phencyclidine (PCP),c1ccc(C2(N3CCCCC3)CCCCC2)cc1,-4.48,3.3113112148259076e-05,1
M1,CN(C)CC1CCCCC1(O)c1cccc(O)c1,-4.7799463,1.659792126086774e-05,1
C,O=C(Nc1cccc(C(F)(F)F)c1)c1ccccc1NCc1ccncc1,-5.158072,6.949091017500826e-06,0
19,CCc1ccc(NC(=O)c2ccnn2CCc2ccncc2)cc1,-5.0116143,9.736115111971592e-06,1
LEF553,N=C(N)NCCC[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(N)=O,-7.7600002,1.7378000284627017e-08,0
36,Cn1c(C2=CCN(CCCN3c4ccccc4Sc4ccc(CC(=O)O)cc43)CC2)cc(=O)n(C)c1=O,-4.8289509000000015,1.4826857035614904e-05,1
234-Cortisone,C[C@@]12CCC(=O)C=C1CC[C@H]1[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)CC(=O)[C@H]12,-4.5086384000000015,3.09999933020973e-05,1
Meloxicam,Cc1cnc(N/C(O)=C2/C(=O)c3ccccc3S(=O)(=O)N2C)s1,-4.7058601,1.968520310286803e-05,1
228-Raffinose,OC[C@H]1O[C@@](CO)(OC2O[C@H](COC3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O,-7.309804,4.899999097065019e-08,0
5m,c1ccc(Cn2nnnc2C(c2ccc(Cn3cncn3)cc2)N2CCCN(C3CCC3)CC2)cc1,-6.3000002,5.011870028220744e-07,0
Lisinopril,NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@@H]1C(=O)O,-6.6599998,2.1877626314512472e-07,0
N-Acetyl-D-valine Phenethylamide (9a),CC(=O)N[C@@H](C(=O)NCCc1ccccc1)C(C)C,-4.4610906,3.4586721748340554e-05,1
N-(4-Chlorophenyl)-1-(2-(pyridin-4-yl)ethyl)-1H-pyrazole-5-carboxamide (11),O=C(Nc1ccc(Cl)cc1)c1ccnn1CCc1ccncc1,-5.1590075,6.934138310805384e-06,0
Isovitexin (10),O=c1cc(-c2ccc(O)cc2)oc2cc(O)c([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)c12,-6.2003298,6.304783820480748e-07,0
Cerivastatin,COCc1c(C(C)C)nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)c1-c1ccc(F)cc1,-5.27,5.370317963702533e-06,0
meloxicam,Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1,-4.71,1.9498445997580456e-05,1
N-acetyl-tryptophanamide,CC(=O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12,-5.619999900000002,2.3988334713712374e-06,0
preladenant,COCCOc1ccc(N2CCN(CCn3ncc4c3nc(N)n3nc(-c5ccco5)nc43)CC2)cc1,-5.3499999,4.466836950036728e-06,0
Tamoxifen,CC/C(=C(/c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,-4.3221111,4.7630912315062685e-05,1
OXc,CC(=O)c1ccc(N2CC(CN)OC2=O)cc1,-4.8499999,1.4125378698715803e-05,1
Ac-Trp-Ala-Gly-Gly-Asp-Ala-NH2,CC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(C)C(=O)NCC(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(C)C(N)=O,-7.4981046,3.1761090113929106e-08,0
Chlortetracycline,CN(C)[C@@H]1C(=O)C(C(N)=O)=C(O)[C@@]2(O)C(=O)C3=C(O)c4c(O)ccc(Cl)c4[C@@](C)(O)[C@H]3C[C@@H]12,-6.3200002,4.78629871905386e-07,0
Tinidazole,CCS(=O)(=O)CCn1c(N(O)O)cnc1C,-4.52,3.0199517204020192e-05,1
hydralazine,NNc1nncc2ccccc12,-5.170000099999998,6.760828197181441e-06,0
1,CCCN(Cc1ccoc1)C(=O)c1cc(C)cc(OCC2(CON=C(N)N)CC2)c1,-5.387216099999999,4.100000408591647e-06,0
884-14b,C=C(c1ccccc1)[C@H]1OC[C@@H](NC(=O)Cc2ccccc2)[C@H](C)O1,-5.050365900000001,8.905003612912307e-06,1
65,CC(=O)c1sc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C,-5.221849,5.999996540823129e-06,0
Pravastatin,CCC(C)C(=O)O[C@@H]1C[C@@H](O)C=C2C=C[C@@H](C)[C@@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@@H]21,-5.869999900000002,1.348963193201867e-06,0
Met-enkephalin,CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)O,-7.380000099999998,4.168692874826252e-08,0
20-Hydroxyecdysone (25),CC(C)(O)CC[C@@H](O)[C@](C)(O)[C@H]1CC[C@@]2(O)C3=CC(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@@]4(C)C3CC[C@]12C,-4.79,1.62181009735893e-05,1
12,COCc1ccc2c(C(C(=O)NS(=O)(=O)c3ccc(C)cc3OC)c3ccc4c(c3)OCO4)cn(C)c2c1,-5.3005152,5.005930318198146e-06,0
hexapeptide 41,C[C@@H]1NC(=O)[C@H](C)N(C)C(=O)[C@@H](C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@@H](C)N(C)C(=O)[C@@H](C)NC1=O,-5.2600002,5.495406207847575e-06,0
Penicillin G,CC1(C)S[C@H]2[C@@H](NC(=O)Cc3ccccc3)C(=O)N2[C@@H]1C(=O)O,-5.8697934,1.3496047558905653e-06,0
Propylparaben,CCCOC(=O)c1ccc(O)cc1,-4.3899999,4.073803716068987e-05,1
T2007,O=C1NC(=O)C(c2ccccc2)(c2ccccc2)C(=O)N1,-4.46,3.467368504525317e-05,1
Simvastatin,CCC(C)(C)C(=O)O[C@@H]1C[C@H](C)C=C2C=C[C@@H](C)[C@@H](CC[C@@H]3C[C@H](O)CC(=O)O3)[C@@H]21,-5.170000099999998,6.760828197181441e-06,0
-,O=Cc1ccncc1,-4.180557299999999,6.598461696531617e-05,1
Sulfasalazine,O=C(O)C1=C/C(=N\Nc2ccc(S(=O)(=O)Nc3ccccn3)cc2)C=CC1=O,-6.5171175,3.0400624141193833e-07,0
Pranoprofen; pyranoprofen,CC(C(=O)O)c1ccc2c(c1)Cc1cccnc1O2,-4.3899999,4.073803716068987e-05,1
hexapeptide 18,C[C@@H]1NC(=O)[C@@H](C)N(C)C(=O)[C@H](C)NC(=O)[C@@H](C)NC(=O)[C@@H](C)N(C)C(=O)[C@H](C)NC1=O,-5.3000002,5.011870028220744e-06,0
4,CC(=O)N[C@H](Cc1ccccc1)C(=O)N(C)[C@H](Cc1ccccc1)C(=O)N[C@H](Cc1ccccc1)C(N)=O,-5.0900002,8.128301418418988e-06,1
Arzanol,CCc1oc(O)c(Cc2c(O)c(CC=C(C)C)c(O)c(C(C)=O)c2O)c(=O)c1C,-4.71,1.9498445997580456e-05,1
N-Acetylglycine Phenethylamide (7),CC(=O)NCC(=O)NCCc1ccccc1,-4.6597776,2.1888822524831937e-05,1
Imatinib,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1,-5.3899999,4.073803716068988e-06,0
Rivulobirin A,C=C(C)C(COc1c2occc2cc2ccc(=O)oc12)OC(C)(C)C(O)COc1c2occc2cc2ccc(=O)oc12,-4.48,3.3113112148259076e-05,1
Nifedipine,COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1N(O)O,-4.3319983,4.6558791601424286e-05,1
G6264,CCOC(=O)CCN1CC(=O)N(C)c2ccc(NCc3ccc(C(=N)N)cc3)cc2C1=O,-6.8519359,1.4062550660205126e-07,0
AACV,C=C1NC(N)=Nc2c1ncn2COCCOC(=O)[C@@H](C)N,-5.6900001,2.041737474542049e-06,0
fexofenadine hydrochloride,CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1.Cl,-5.6999998,1.9952632338213455e-06,0
25,COCCCOc1ccc(-c2nccc(-c3cc4c([nH]3)C3(CCCNC3)CNC4=O)n2)cn1,-5.380000099999998,4.168692874826252e-06,0
PNU-184470,CC(=S)NC[C@H]1CN(c2ccc(N3CCCS(=O)(=O)CC3)c(F)c2)C(=O)O1,-4.6391363,2.2954281324989513e-05,1
Lys-FITC-OCH3,COC(=O)[C@H](N)CCCCNC(=S)Nc1ccc2c(c1)C(=O)OC21c2ccc(O)cc2Oc2cc(O)ccc21,-5.8313413,1.4745472719752476e-06,0
3,COC(=O)C[C@@H](C(=O)NN(Cc1ccc(/C=C\c2ccccc2)cc1)C[C@@](O)(Cc1ccccc1)C(=O)NC1c2ccccc2C[C@H]1O)C(C)(C)C,-5.079999900000002,8.31763962623376e-06,1
neolignan smi08,C=CCc1cc(OC)c(OC(C)C(O)c2cc(OC)c(OC)c(OC)c2)c(OC)c1,-4.5500002,2.8183816333514456e-05,1
hexapeptide 60,C[C@H]1C(=O)N[C@H](C)C(=O)N(C)[C@H](C)C(=O)N(C)[C@@H](C)C(=O)N(C)[C@H](C)C(=O)N(C)[C@@H](C)C(=O)N1C,-5.3000002,5.011870028220744e-06,0
N-Acetyl-D-leucine Phenethylamide (10),CC(=O)N[C@H](CC(C)C)C(=O)NCCc1ccccc1,-4.513246499999998,3.067280544973286e-05,1
1029-Dihydrotetrabenazine isomer,COc1cc2c(cc1OC)C1CC(O)C(CC(C)C)CN1CC2,-4.598685700000001,2.5194996363021964e-05,1
imipramine,CN(C)CCCN1c2ccccc2CCc2ccccc21,-4.8509998,1.409289447423499e-05,1
Spironolactone,C=C[C@@H]1CN2CC[C@@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12,-4.5008955,3.155763872377437e-05,1
5'-L-valyl-L-phenylalanyl-floxuridine,CC(C)C(N)C(=O)NC(Cc1ccccc1)C(=O)OC[C@@H]1O[C@H](n2cc(F)c(=O)[nH]c2=O)C[C@H]1O,-6.080461,8.308813291753658e-07,0
Astemizole,COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1,-5.1500001,7.0794562137361614e-06,0
Cerulenin,C/C=C/C/C=C/CCC(=O)[C@@H]1O[C@@H]1C(N)=O,-5.4224062,3.7808878903878936e-06,0
30d,O=C(NC1(C(=O)N[C@H](Cc2ccccc2)C(=O)NCC2CCN(C3CCOCC3)CC2)CCCC1)c1cc2ccccc2s1,-5.7979398,1.5924294473524644e-06,0
32b,COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)NS(=O)(=O)C6CC6)C[C@H]5/C=C\CCCCN(C)C(=O)[C@@H]4C3)cc(-c3nc(C(C)C)cs3)nc2c1,-4.8880281,1.2941121062699005e-05,1
dexamethasone b D glucoside,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO[C@H]1O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]1O,-6.54,2.8840315031266057e-07,0
hexapeptide 24,C[C@@H]1NC(=O)[C@@H](C)NC(=O)[C@H](C)N(C)C(=O)[C@@H](C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)N(C)C1=O,-5.8200002,1.5135605514156553e-06,0
cyclo[Trp-Ala-Gly-Gly-Asp-Ala],CC1NC(=O)C(CC(=O)O)NC(=O)CNC(=O)CNC(=O)C(C)NC(=O)C(Cc2c[nH]c3ccccc23)NC1=O,-7.0307584,9.316259991272929e-08,0
Cyclo(-PFMewKTMeF-) (7),C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)N(C)C(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccccc2)N(C)C1=O,-6.570000200000001,2.691533564429613e-07,0
Sulfamethizole,Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1,-5.8393164,1.4477167526942237e-06,0
Byankangelicol,COc1c2ccoc2c(OCC2OC2(C)C)c2oc(=O)ccc12,-4.3000002,5.011870028220744e-05,1
methylscopolamine,C[N+]1(C)[C@H]2CC(OC(=O)[C@H](CO)c3ccccc3)C[C@H]1C1OC12.[Br-],-6.1599998,6.918312895189466e-07,0
Alfuzosin,COc1cc2nc(N(C)CCCNC(=O)C3CCCO3)nc(N)c2cc1OC,-5.6399999,2.290868180259603e-06,0
PNU200603,N=C(N)c1ccc2[nH]c(-c3ccccn3)nc2c1,-6.4699998,3.3884431218273895e-07,0
22,Cc1ccc(NC(=O)c2nscc2NCc2ccncc2)cc1C(F)(F)F,-5.2295737,5.894219433667589e-06,0
21,Cn1c(N2CCN(CCCN3c4ccccc4Sc4ccc(C(=O)O)cc43)CC2)cc(=O)n(C)c1=O,-5.0,1e-05,1
PB-27,Cn1cncc1CN1CC(N(Cc2ccccn2)S(=O)(=O)c2ccccn2)Cc2cc(C#N)ccc21,-5.7979398,1.5924294473524644e-06,0
Gefitinib,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1,-4.48,3.3113112148259076e-05,1
5-chlorosalicylic acid,O=C(O)c1cc(Cl)ccc1O,-4.98,1.0471285480508985e-05,1
